Last reviewed · How we verify

NCT04922866

Predictive Nomogram for Postoperative Acute Kidney Injury (AKI) in Elderly Patients Following Liver Resection

Completed Last updated 11 March 2022
What this trial tests

trial testing no intervention in Postoperative Acute Kidney Injury in 843 participants. Completed in 30 January 2022.

Timeline
1 September 2020
Primary endpoint
30 January 2022
30 January 2022

Quick facts

Lead sponsorChinese PLA General Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment843
Start date1 September 2020
Primary completion30 January 2022
Estimated completion30 January 2022
Sites2 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Chinese PLA General Hospital

Who can join

Adults 65 to 100, any sex, with Postoperative Acute Kidney Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acute kidney injury (AKI) is a severe complication after liver resection and is associated with morbidity and mortality. The incidence of postoperative AKI is significantly higher in elderly patients, especially in those with comorbidities. There is currently limited evidence on the incidence and associations of postoperative AKI in elderly patients following liver resection. This study will evaluate the incidence and associations of AKI in elderly patients after liver resection and its impact on postoperative mortality.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Development and validation of a risk nomogram for postoperative acute kidney injury in older patients undergoing liver resection: a pilot study.
    Yu Y, Zhang C, Zhang F, Liu C, et al · · 2022 · cited 9× · PMID 35026992 · DOI 10.1186/s12871-022-01566-z

Verify or expand the search:

Other trials of no intervention

Trials testing the same drug.

Other recruiting trials for Postoperative Acute Kidney Injury

Currently open trials in the same condition.

Other Chinese PLA General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04922866.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing